139 related articles for article (PubMed ID: 28507081)
41. B-cells and mixed cryoglobulinemia.
Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
[TBL] [Abstract][Full Text] [Related]
42. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
43. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
[TBL] [Abstract][Full Text] [Related]
44. [Role of hepatitis C virus in mixed cryoglobulinemia in patients with chronic hepatitis].
Adinolfi LE; Utili R; Attanasio V; Zampino R; Pizzella T; Nardiello S; Ruggiero G
Ann Ital Med Int; 1995; 10(2):85-8. PubMed ID: 7619656
[TBL] [Abstract][Full Text] [Related]
45. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.
Isnardi I; Ng YS; Menard L; Meyers G; Saadoun D; Srdanovic I; Samuels J; Berman J; Buckner JH; Cunningham-Rundles C; Meffre E
Blood; 2010 Jun; 115(24):5026-36. PubMed ID: 20231422
[TBL] [Abstract][Full Text] [Related]
46. Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.
Kong F; Zhang W; Feng B; Zhang H; Rao H; Wang J; Cong X; Wei L
Virol J; 2015 Jul; 12():100. PubMed ID: 26129991
[TBL] [Abstract][Full Text] [Related]
47. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
49. [Mixed cryoglobulinemia and the hepatitis C virus].
Bulfoni A
Minerva Med; 1995 May; 86(5):193-8. PubMed ID: 7566548
[TBL] [Abstract][Full Text] [Related]
50. Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency.
Visentini M; Marrapodi R; Conti V; Mitrevski M; Camponeschi A; Lazzeri C; Carbonari M; Catizone A; Quinti I; Fiorilli M
J Allergy Clin Immunol; 2014 Aug; 134(2):401-10. PubMed ID: 24792875
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
[TBL] [Abstract][Full Text] [Related]
52. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.
Lee KC; Cheng YT; Lin CY; Kuo CJ; Chien RN; Yeh CT; Chang ML
Eur J Clin Invest; 2020 Jan; 50(1):e13189. PubMed ID: 31782138
[TBL] [Abstract][Full Text] [Related]
53. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
Visentini M; Fiorilli M; Casato M
Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
[TBL] [Abstract][Full Text] [Related]
54. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
55. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
Ayad MW; Elbanna AA; Elneily DA; Sakr AS
Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
[TBL] [Abstract][Full Text] [Related]
56. Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus-infected individuals.
Tucci FA; Kitanovski S; Johansson P; Klein-Hitpass L; Kahraman A; Dürig J; Hoffmann D; Küppers R
Blood; 2018 Feb; 131(5):546-557. PubMed ID: 29242186
[TBL] [Abstract][Full Text] [Related]
57. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia.
Monteverde A; Ballarè M; Pileri S
Springer Semin Immunopathol; 1997; 19(1):99-110. PubMed ID: 9266634
[TBL] [Abstract][Full Text] [Related]
58. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
59. Evidence of hepatitis C virus antibodies in the cryoprecipitate of patients with mixed cryoglobulinemia.
Muñoz-Fernández S; Barbado FJ; Martín Mola E; Gijón-Baños J; Martinez Zapico R; Quevedo E; Arribas JR; González Anglada I; Vázquez JJ
J Rheumatol; 1994 Feb; 21(2):229-33. PubMed ID: 7514225
[TBL] [Abstract][Full Text] [Related]
60. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
Johnson RJ; Gretch DR; Yamabe H; Hart J; Bacchi CE; Hartwell P; Couser WG; Corey L; Wener MH; Alpers CE
N Engl J Med; 1993 Feb; 328(7):465-70. PubMed ID: 7678440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
